BENECCHI CHRISTOPHER (Chief Commercial Officer) reported 1 transaction at SAGE THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/14/2025ACC: 0001562180-25-001202
Officer· Chief Commercial Officer
Since Sep 2021
-822.00
Net shares
Net seller
$5.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
822.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−822.00
Price / share
$7.18
Trade value
$5.90K
% of position
1.8%
2/13/2025
44.74K→43.91K
Total
Net shares
−822.00
Net value
-$5.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2025 | F · Tax Withholding | −822.00 | $7.18 | $5.90K | 1.8% | 44.74K | 43.91K |
| Total | −822.00 | -$5.90K | ||||||
Derivative Transactions0
No derivative transactions reported